These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 15226397)

  • 1. Farnesyltransferase inhibitors disrupt EGF receptor traffic through modulation of the RhoB GTPase.
    Wherlock M; Gampel A; Futter C; Mellor H
    J Cell Sci; 2004 Jul; 117(Pt 15):3221-31. PubMed ID: 15226397
    [TBL] [Abstract][Full Text] [Related]  

  • 2. RhoB regulates endosome transport by promoting actin assembly on endosomal membranes through Dia1.
    Fernandez-Borja M; Janssen L; Verwoerd D; Hordijk P; Neefjes J
    J Cell Sci; 2005 Jun; 118(Pt 12):2661-70. PubMed ID: 15944396
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Geranylgeranylated RhoB mediates suppression of human tumor cell growth by farnesyltransferase inhibitors.
    Du W; Prendergast GC
    Cancer Res; 1999 Nov; 59(21):5492-6. PubMed ID: 10554025
    [TBL] [Abstract][Full Text] [Related]  

  • 4. RhoB-dependent modulation of postendocytic traffic in polarized Madin-Darby canine kidney cells.
    Rondanino C; Rojas R; Ruiz WG; Wang E; Hughey RP; Dunn KW; Apodaca G
    Traffic; 2007 Jul; 8(7):932-49. PubMed ID: 17547697
    [TBL] [Abstract][Full Text] [Related]  

  • 5. RhoB and the mammalian Diaphanous-related formin mDia2 in endosome trafficking.
    Wallar BJ; Deward AD; Resau JH; Alberts AS
    Exp Cell Res; 2007 Feb; 313(3):560-71. PubMed ID: 17198702
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TSG101 interaction with HRS mediates endosomal trafficking and receptor down-regulation.
    Lu Q; Hope LW; Brasch M; Reinhard C; Cohen SN
    Proc Natl Acad Sci U S A; 2003 Jun; 100(13):7626-31. PubMed ID: 12802020
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cell growth inhibition by farnesyltransferase inhibitors is mediated by gain of geranylgeranylated RhoB.
    Du W; Lebowitz PF; Prendergast GC
    Mol Cell Biol; 1999 Mar; 19(3):1831-40. PubMed ID: 10022870
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Geranylgeranylated, but not farnesylated, RhoB suppresses Ras transformation of NIH-3T3 cells.
    Mazières J; Tillement V; Allal C; Clanet C; Bobin L; Chen Z; Sebti SM; Favre G; Pradines A
    Exp Cell Res; 2005 Apr; 304(2):354-64. PubMed ID: 15748883
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LIM kinase 1: evidence for a role in the regulation of intracellular vesicle trafficking of lysosomes and endosomes in human breast cancer cells.
    Nishimura Y; Yoshioka K; Bernard O; Himeno M; Itoh K
    Eur J Cell Biol; 2004 Aug; 83(7):369-80. PubMed ID: 15503860
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role for RhoB and PRK in the suppression of epithelial cell transformation by farnesyltransferase inhibitors.
    Zeng PY; Rane N; Du W; Chintapalli J; Prendergast GC
    Oncogene; 2003 Feb; 22(8):1124-34. PubMed ID: 12606940
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Farnesyltransferase inhibitors alter the prenylation and growth-stimulating function of RhoB.
    Lebowitz PF; Casey PJ; Prendergast GC; Thissen JA
    J Biol Chem; 1997 Jun; 272(25):15591-4. PubMed ID: 9188444
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transformation-selective apoptotic program triggered by farnesyltransferase inhibitors requires Bin1.
    DuHadaway JB; Du W; Donover S; Baker J; Liu AX; Sharp DM; Muller AJ; Prendergast GC
    Oncogene; 2003 Jun; 22(23):3578-88. PubMed ID: 12789266
    [TBL] [Abstract][Full Text] [Related]  

  • 13. RhoB alteration is necessary for apoptotic and antineoplastic responses to farnesyltransferase inhibitors.
    Liu Ax; Du W; Liu JP; Jessell TM; Prendergast GC
    Mol Cell Biol; 2000 Aug; 20(16):6105-13. PubMed ID: 10913192
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Non-Ras targets of farnesyltransferase inhibitors: focus on Rho.
    Lebowitz PF; Prendergast GC
    Oncogene; 1998 Sep; 17(11 Reviews):1439-45. PubMed ID: 9779989
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Farnesyltransferase inhibitors: antineoplastic properties, mechanisms of action, and clinical prospects.
    Prendergast GC; Oliff A
    Semin Cancer Biol; 2000 Dec; 10(6):443-52. PubMed ID: 11170866
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phosphorylation of RhoB by CK1 impedes actin stress fiber organization and epidermal growth factor receptor stabilization.
    Tillement V; Lajoie-Mazenc I; Casanova A; Froment C; Penary M; Tovar D; Marquez R; Monsarrat B; Favre G; Pradines A
    Exp Cell Res; 2008 Sep; 314(15):2811-21. PubMed ID: 18590726
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Geranylgeranylated RhoB is sufficient to mediate tissue-specific suppression of Akt kinase activity by farnesyltransferase inhibitors.
    Liu A; Prendergast GC
    FEBS Lett; 2000 Sep; 481(3):205-8. PubMed ID: 11007964
    [TBL] [Abstract][Full Text] [Related]  

  • 18. RhoB prenylation is driven by the three carboxyl-terminal amino acids of the protein: evidenced in vivo by an anti-farnesyl cysteine antibody.
    Baron R; Fourcade E; Lajoie-Mazenc I; Allal C; Couderc B; Barbaras R; Favre G; Faye JC; Pradines A
    Proc Natl Acad Sci U S A; 2000 Oct; 97(21):11626-31. PubMed ID: 11027361
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of dominant negative rab5 in HeLa cells regulates endocytic trafficking distal from the plasma membrane.
    Dinneen JL; Ceresa BP
    Exp Cell Res; 2004 Apr; 294(2):509-22. PubMed ID: 15023538
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of the microtubule cytoskeleton in traffic of EGF through the lacrimal acinar cell endomembrane network.
    Xie J; Qian L; Wang Y; Hamm-Alvarez SF; Mircheff AK
    Exp Eye Res; 2004 Jun; 78(6):1093-106. PubMed ID: 15109916
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.